Cochlear implant drug delivery system, EP3684456A2
Summary
The European Patent Office published patent application EP3684456A2 by Cochlear Limited for an implantable therapeutic substance delivery system designed for cochlear implants. The system enables localized delivery of therapeutic substances to the inner ear through an implanted device. The application covers designated states across the European Economic Area.
What changed
EPO published patent application EP3684456A2 for an implantable therapeutic substance delivery system for cochlear implants. The system allows localized drug delivery to the inner ear via an implanted therapeutic substance delivery device.
Competitors developing cochlear implant systems with drug delivery capabilities should conduct freedom-to-operate analyses. Medical device manufacturers entering the hearing loss treatment market may need to evaluate licensing options or design-around strategies.
What to do next
- Review patent claims for freedom-to-operate analysis
- Monitor for patent grant or opposition period
- Assess competitive landscape impact on cochlear implant drug delivery
Archived snapshot
Apr 8, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
IMPLANTABLE THERAPEUTIC SUBSTANCE DELIVERY SYSTEM
Publication EP3684456A2 Kind: A2 Apr 01, 2026
Applicants
Cochlear Limited
Inventors
SMYTH, Daniel, KIRK, Jonathon, TREABA, Claudiu G., DUECK, Wolfram Frederik, EECKHOUDT, Stijn, WALRAEVENS, Joris, MURPHY, Richard Bruce
IPC Classifications
A61M 31/00 20060101AFI20210511BHEP A61F 11/00 20060101ALI20210511BHEP A61M 39/02 20060101ALI20210511BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for ChangeBridge: EPO Bulletin - Prosthetics (A61F)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Prosthetics (A61F) publishes new changes.